Debo Chen

419 total citations
29 papers, 300 citations indexed

About

Debo Chen is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Debo Chen has authored 29 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 14 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Debo Chen's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (6 papers) and Ferroptosis and cancer prognosis (5 papers). Debo Chen is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (6 papers) and Ferroptosis and cancer prognosis (5 papers). Debo Chen collaborates with scholars based in China and Taiwan. Debo Chen's co-authors include Zhidong Huang, Junfan Pan, Helin Wang, Peidong Yang, Liangqiang Li, Chuan Wang, Xi Zhang, Jialin Chen, Qinglan Wang and Bo Ma and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and Frontiers in Immunology.

In The Last Decade

Debo Chen

24 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debo Chen China 10 253 162 48 48 14 29 300
Jinze Shen China 10 220 0.9× 179 1.1× 34 0.7× 35 0.7× 17 1.2× 26 274
Olga Vera Spain 10 209 0.8× 146 0.9× 46 1.0× 19 0.4× 9 0.6× 19 280
Qingzhi Kong China 5 253 1.0× 202 1.2× 39 0.8× 41 0.9× 18 1.3× 9 306
Saifei He China 10 205 0.8× 149 0.9× 55 1.1× 33 0.7× 19 1.4× 17 278
Nam-Gu Her South Korea 5 174 0.7× 114 0.7× 23 0.5× 48 1.0× 17 1.2× 5 249
Chun-Lin Lin United States 8 205 0.8× 127 0.8× 68 1.4× 78 1.6× 21 1.5× 9 287

Countries citing papers authored by Debo Chen

Since Specialization
Citations

This map shows the geographic impact of Debo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debo Chen more than expected).

Fields of papers citing papers by Debo Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debo Chen. The network helps show where Debo Chen may publish in the future.

Co-authorship network of co-authors of Debo Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Debo Chen. A scholar is included among the top collaborators of Debo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debo Chen. Debo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Peidong, et al.. (2026). Protein Nanovaccines Co-Delivering STING Agonists for Enhanced Dendritic Cell Activation and Antitumor Immunity. ACS Applied Materials & Interfaces. 18(3). 4818–4829.
2.
3.
4.
5.
Chen, Debo, et al.. (2024). USP35 promotes breast cancer progression by regulating PFK-1 ubiquitination to mediate glycolysis. American Journal of Physiology-Cell Physiology. 328(2). C355–C366. 3 indexed citations
6.
Huang, Zhidong, Jinhui Wang, Linwei Li, et al.. (2024). RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway. Journal of Translational Medicine. 22(1). 1052–1052. 2 indexed citations
7.
Li, T., Yiqin Huang, Xinhai Zhang, et al.. (2024). RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer. Scientific Reports. 14(1). 26075–26075. 1 indexed citations
8.
Chen, Debo, et al.. (2023). A retrieval model of surface geochemistry composition based on remotely sensed data. Open Geosciences. 15(1). 2 indexed citations
9.
10.
Chen, Jialin, et al.. (2023). A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning. Frontiers in Genetics. 14. 1193944–1193944. 16 indexed citations
11.
12.
Chen, Debo, Zhishan Chen, Qinglan Wang, et al.. (2023). LncRNA SEMA3B‐AS1 suppresses the tumor‐initiating characteristics of triple negative breast cancer via engaging in MLL4‐mediated H3K4 trimethylation. Molecular Carcinogenesis. 63(3). 371–383. 2 indexed citations
13.
Zhang, Xi, Xin Mu, Ou Huang, et al.. (2022). ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis. BMC Cancer. 22(1). 226–226. 9 indexed citations
14.
Yang, Peidong, et al.. (2021). Comparison of the Gut Microbiota in Patients with Benign and Malignant Breast Tumors: A Pilot Study. Evolutionary Bioinformatics. 17. 3243618725–3243618725. 36 indexed citations
15.
Huang, Zhidong, Junjing Li, Jialin Chen, & Debo Chen. (2021). Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer. Frontiers in Genetics. 12. 748279–748279. 18 indexed citations
16.
Zheng, Juanjuan, et al.. (2020). Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis. Translational Cancer Research. 9(10). 5969–5978. 1 indexed citations
17.
Fu, Fangmeng, et al.. (2020). Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort study. Translational Cancer Research. 9(10). 5900–5908. 3 indexed citations
18.
Wang, Qinglan, Meimei Liu, Xiaolan Lin, et al.. (2020). Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer. Journal of Cancer. 12(3). 740–753. 16 indexed citations
19.
20.
Jiang, Meng, Ling Liu, Debo Chen, et al.. (2019). Single molecule chromogenic in situ hybridization assay for RNA visualization in fixed cells and tissues. RNA. 25(8). 1038–1046. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinze Shen Breakdown of academic impact, for papers by Olga Vera Breakdown of academic impact, for papers by Qingzhi Kong Breakdown of academic impact, for papers by Saifei He Breakdown of academic impact, for papers by Nam-Gu Her Breakdown of academic impact, for papers by Chun-Lin Lin
Rankless by CCL
2026